NAPEPLD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.363400E-01
Normal-vs-Stage2
7.703000E-01
Normal-vs-Stage3
1.433820E-01
Normal-vs-Stage4
2.762400E-01
Stage1-vs-Stage2
1.184590E-01
Stage1-vs-Stage3
5.634300E-02
Stage1-vs-Stage4
8.564800E-01
Stage2-vs-Stage3
5.144000E-02
Stage2-vs-Stage4
9.792400E-02
Stage3-vs-Stage4
5.830500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.878600E-01
Normal-vs-AfricanAmerican
6.641800E-01
Normal-vs-Asian
9.855000E-01
Caucasian-vs-AfricanAmerican
5.672400E-01
Caucasian-vs-Asian
5.891400E-01
AfricanAmerican-vs-Asian
5.019400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.266400E-01
Normal-vs-Female
8.583000E-01
Male-vs-Female
5.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.865600E-01
Normal-vs-Age(41-60Yrs)
6.357400E-01
Normal-vs-Age(61-80Yrs)
8.876200E-01
Normal-vs-Age(81-100Yrs)
7.057200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.093400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.279600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.881400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.402400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.663200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.659400E-01
Normal-vs-Daily Drinker
8.655400E-01
Normal-vs-Weekly Drinker
9.654800E-01
Normal-vs-Occasional Drinker
7.221000E-01
Normal-vs-Social Drinker
4.891400E-01
Non Drinker-vs-Daily Drinker
3.145200E-01
Non Drinker-vs-Weekly Drinker
8.212000E-01
Non Drinker-vs-Occasional Drinker
9.542000E-01
Non Drinker-vs-Social Drinker
5.484400E-01
Daily Drinker-vs-Weekly Drinker
7.870600E-01
Daily Drinker-vs-Occasional Drinker
3.362600E-01
Daily Drinker-vs-Social Drinker
1.359780E-01
Weekly Drinker-vs-Occasional Drinker
8.409400E-01
Weekly Drinker-vs-Social Drinker
5.941400E-01
Occasional Drinker-vs-Social Drinker
4.569000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.672100E-02
Normal-vs-Grade 2
1.342190E-02
Normal-vs-Grade 3
6.012100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.533400E-01
Grade 1-vs-Grade 3
5.935700E-02
Grade 1-vs-Grade 4
3.672100E-02
Grade 2-vs-Grade 3
2.138800E-01
Grade 2-vs-Grade 4
1.342190E-02
Grade 3-vs-Grade 4
6.012100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.995000E-01
Normal-vs-NonDiabetic
8.223800E-01
Diabetic-vs-NonDiabetic
6.035600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.771200E-01
Normal-vs-NoPancreatitis
9.166400E-01
Pancreatitis-vs-NoPancreatitis
3.809400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.468800E-01
Normal-vs-N1
7.760200E-01
N0-vs-N1
7.997000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.427200E-01
Normal-vs-TP53-NonMutant
4.999400E-01
TP53-Mutant-vs-TP53-NonMutant
9.545600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
